Immediate Impact

1 by Nobel laureates 67 standout
Sub-graph 1 of 23

Citing Papers

Type 2 Diabetes Mellitus: New Pathogenetic Mechanisms, Treatment and the Most Important Complications
2025 Standout
Tiragolumab in combination with atezolizumab and bevacizumab in patients with unresectable, locally advanced or metastatic hepatocellular carcinoma (MORPHEUS-Liver): a randomised, open-label, phase 1b–2, study
2025 Standout
2 intermediate papers

Works of Leona Dold being referenced

Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinoma
2019
Genetic polymorphisms associated with fatty liver disease and fibrosis in HIV positive patients receiving combined antiretroviral therapy (cART)
2017

Author Peers

Author Last Decade Papers Cites
Leona Dold 245 238 47 93 33 485
Meenakshi Sachdeva 61 78 61 133 34 484
Tokuhiro Matsubara 136 98 88 197 27 493
Àngels Vilella 139 215 205 71 26 558
María Trapero-Marugán 244 231 55 56 28 432
Orrawadee Hanvivatvong 217 156 148 85 20 525
Edward Alabraba 260 173 263 77 21 488
Katsuhisa Nakatsuka 328 334 191 117 27 565
Yoshihiro Edamoto 195 221 72 12 26 461
K.‐H. Meyer zum Büschenfelde 232 215 61 135 43 571
Xiaoshun He 166 161 181 165 25 564

All Works

Loading papers...

Rankless by CCL
2026